Living Conditions of Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma in the Côte d'Or Region

Completed

• Conditions: Diffuse Large Cell Diffuse Lymphoma; Follicular Lymphoma

• Registration Number: NCT04859920
• Lead Sponsor: Centre Hospitalier Universitaire Dijon

Brief Summary

The development of new diagnostic tools and targeted therapy have significantly improved the management of non-Hodgkin's malignant lymphomas and thus their long-term prognosis. However, in the study of improved patient management, survival is not the only measurable indicator and preservation of quality of life is an essential component. In addition, there is little existing data regarding the determinants of quality of life in patients with diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) in the general population in France.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-01
• Study First Submitted: 2021-04-22
• Study First Submitted QC: 2021-04-22
• Study First Posted: 2021-04-26
• Primary Completion: 2021-04-30
• Study Completion: 2021-04-30
• Status Verified: 2022-01
• Last Update Submitted: 2023-01-31
• Last Update Posted: 2023-02-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 157

Inclusion Criteria

• Patients diagnosed with DLBCL or FL between January 1, 2010 and December 31, 2017,
• Alive as of January 1, 2021,
• Updated patient address.

Exclusion Criteria

• Other forms of Hematologic Malignancies at diagnosis,
• Minors.
• Person subject to legal protection (curatorship, guardianship)
• Person subject to a judicial safeguard measure
• Pregnant, parturient or breastfeeding woman
• Adults incapable of giving consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Specific questionnaire QLQ-C30	At inclusion
Generic Questionnaire SF-12	At inclusion

Trial Locations

Locations (1)

Chu Dijon Bourogne; 🇫🇷 Dijon, France